Prosight Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Buy |
1,079,673
+470,421
| +77% | +$4.41M | 2.47% | 14 |
|
|
2025
Q1 | $7.48M | Sell |
609,252
-10,748
| -2% | -$132K | 2.46% | 16 |
|
|
2024
Q4 | $8.2M | Buy |
620,000
+65,897
| +12% | +$871K | 2.27% | 17 |
|
|
2024
Q3 | $10.7M | Buy |
554,103
+2,559
| +0.5% | +$49.3K | 2.62% | 16 |
|
|
2024
Q2 | $11.3M | Buy |
+551,544
| New | +$11.3M | 3.38% | 10 |
|